David S. Weinberg Named Co-Editor-in-Chief of Gastroenterology, American Gastroenterological Association’s Premier Journal

David S. Weinberg, MD, MSc
David S. Weinberg, MD, MSc

PHILADELPHIA (August 6, 2021)—David S. Weinberg, MD, MSc, chair of the Department of Medicine at Fox Chase Cancer Center, was recently named one of two new editors-in-chief of Gastroenterology.

Gastroenterology is the premier journal of the American Gastroenterological Association and is the most highly-cited journal in the field of gastroenterology and hepatology. The journal regularly features articles by leading authorities and reports on the latest treatments for diseases.

“The wonderful thing about the Gastroenterology community is that it is so diverse. We think readers are most interested in research that changes our understanding of the pathogenesis of GI and hepatology diseases or that transforms their management. Our readers, regardless of background, are interested to understand how patient care influences the future direction of research and vice versa,” said Weinberg.

Weinberg will be joining Paul Moayyedi, MB, ChB, PhD, MPH, Audrey Campbell Chair of Ulcerative Colitis Research at McMaster University, as co-editor-in-chief.

“We are excited to be part of history, taking a great journal and continuing to make it relevant for the next generation of clinicians and researchers,” said Weinberg. “All of our associate editors are leaders in their field. Each will contribute enormously to making the best GI journal in the world even better.”

Weinberg joined Fox Chase in 2001 as director of gastroenterology and now serves as the Audrey Weg Schaus and Geoffrey Alan Weg Chair in Medical Science. His research interests focus on the epidemiology of gastrointestinal cancers and associated approaches to reduce risk. He has been ranked as a Top Doctor by Philadelphia Magazine since 2009 and has also been recognized as a Top Doctor by Castle Connolly.

Outside of Fox Chase, Weinberg has been appointed to leadership roles on national committees for a range of groups, including the American Board of Internal Medicine, the National Cancer Institute, the American College of Physicians, and the American Gastroenterological Association.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427